Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 14, 2019

SELL
$278.5 - $352.75 $1.49 Million - $1.89 Million
-5,361 Closed
0 $0
Q3 2018

Oct 03, 2018

SELL
$293.51 - $383.83 $142,058 - $185,773
-484 Reduced 8.28%
5,361 $1.56 Million
Q2 2018

Jul 05, 2018

SELL
$257.52 - $306.91 $246,961 - $294,326
-959 Reduced 14.09%
5,845 $1.7 Million
Q1 2018

Apr 13, 2018

SELL
$260.13 - $367.91 $89,744 - $126,928
-345 Reduced 4.83%
6,804 $1.86 Million
Q4 2017

Jan 29, 2018

BUY
$307.64 - $344.58 $201,504 - $225,699
655 Added 10.09%
7,149 $2.28 Million
Q3 2017

Oct 18, 2017

BUY
$281.15 - $329.69 $1.83 Million - $2.14 Million
6,494
6,494 $2.03 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Verde Servicos Internacionais S.A. Portfolio

Follow Verde Servicos Internacionais S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verde Servicos Internacionais S.A., based on Form 13F filings with the SEC.

News

Stay updated on Verde Servicos Internacionais S.A. with notifications on news.